Indivior (LSE:INDV) ROCE % : 45.68% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Indivior ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Indivior's annualized ROCE % for the quarter that ended in Mar. 2024 was 45.68%.

Indivior ROCE % Historical Data

The historical data trend for Indivior's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior ROCE % Chart

Indivior Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

24.27

-15.98

22.15

-7.80

5.32

Indivior Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															37.28	38.41	-100.81	43.89	45.68

Indivior ROCE % Calculation

Indivior's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	30.02	/	( ( (1452.349 - 836.599)	+	(1543.66 - 1030.95) )	/ 2 )
	=	30.02	/	( (615.75	+	512.71)	/ 2 )
	=	30.02	/	564.23
	=	5.32 %

Indivior's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	223.508	/	( ( (1543.66 - 1030.95)	+	(1143.511 - 677.607) )	/ 2 )
	=	223.508	/	( ( 512.71	+	465.904 )	/ 2 )
	=	223.508	/	489.307
	=	45.68 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Indivior (LSE:INDV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Indivior ROCE % Related Terms

Thank you for viewing the detailed overview of Indivior's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior (LSE:INDV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

INDV:USA INDVl:UK 2IVB:Germany

Address

234 Bath Road, Slough, Berkshire, GBR, SL1 4EE

Website

http://www.indivior.com

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.